Drug · DIN 02322390
ABILIFY
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 13, 2018; first marketed September 30, 2009.
- Drug Identification Number (DIN)
- 02322390
- Company (DIN owner)
- Otsuka Pharmaceutical Co LtdChiyoda-Ku Tokyo, --, Japan
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Aripiprazole N05AX12
- Class
- Human
- Record last updated
- June 19, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ARIPIPRAZOLE | 10 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 1, 2017: NOC 20112New Drug Submission (NDS)
- July 9, 2009: NOC 10372New Drug Submission (NDS)
Other DINs named ABILIFY
- DIN 02322374 · Marketed
- DIN 02322382 · Marketed
- DIN 02322404 · Marketed
- DIN 02322412 · Marketed
- DIN 02322455 · Marketed